Wed, 11 January 2017
Gene-sequencing biotech Illumina soars on a new partnership with IBM’s Watson. Analyst Simon Erickson shares why he’s bullish on Illumina’s future. Plus, we discuss two increasingly competitive industries: groceries and restaurants. |